Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priti Lal

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
Indian Journal of Endocrinology and Metabolism|June 19, 2013
Endoscopic orbital decompression for Graves' orbitopathyPriti Lal, Alok Thakar, Nikhil Tandon
Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India|November 22, 2019
Long Term Outcomes of Intratympanic Dexamethasone in Intractable Unilateral Meniere's DiseasePradeep Pradhan, Priti Lal, Kanwar Sen
American Journal of Clinical Pathology|May 19, 2005
HER-2/neu and topoisomerase IIa gene amplification and protein expression in invasive breast carcinomas: chromogenic in situ hybridization and immunohistochemical analysesRohit Bhargava, Priti Lal, Beiyun Chen
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|November 13, 2004
Feasibility of using tissue microarrays for the assessment of HER-2 gene amplification by fluorescence in situ hybridization in breast carcinomaRohit Bhargava, Priti Lal, Beiyun Chen
The Annals of Otology, Rhinology, and Laryngology|October 9, 2009
Delayed cerebrospinal fluid leak following septoplastyAlok Thakar, Priti Lal, Rohit Verma
American Journal of Clinical Pathology|April 22, 2005
Chromogenic in situ hybridization for the detection of HER-2/neu gene amplification in breast cancer with an emphasis on tumors with borderline and low-level amplification: does it measure up to fluorescence in situ hybridization?Rohit Bhargava, Priti Lal, Beiyun Chen
American Journal of Clinical Pathology|March 4, 2005
Correlation of HER-2 status with estrogen and progesterone receptors and histologic features in 3,655 invasive breast carcinomasPriti Lal, Lee K Tan, Beiyun Chen
American Journal of Otolaryngology|May 5, 2009
Sjogren's syndrome masquerading as nasopharyngeal carcinomaPriti Lal, S Datta Gupta, Alok Thakar
Archives of Pathology & Laboratory Medicine|December 6, 2021
Subcategorization of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens for Predicting ProgressionAnna Budina, Sahar J Farahani, Priti Lal, et al.
The Journal of Molecular Diagnostics : JMD|July 24, 2003
Impact of polysomy 17 on HER-2/neu immunohistochemistry in breast carcinomas without HER-2/neu gene amplificationPriti Lal, Paulo A Salazar, Marc Ladanyi, et al.
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Indian Journal of Endocrinology and Metabolism|June 19, 2013
Endoscopic orbital decompression for Graves' orbitopathyPriti Lal, Alok Thakar, Nikhil Tandon
Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India|November 22, 2019
Long Term Outcomes of Intratympanic Dexamethasone in Intractable Unilateral Meniere's DiseasePradeep Pradhan, Priti Lal, Kanwar Sen
American Journal of Clinical Pathology|May 19, 2005
HER-2/neu and topoisomerase IIa gene amplification and protein expression in invasive breast carcinomas: chromogenic in situ hybridization and immunohistochemical analysesRohit Bhargava, Priti Lal, Beiyun Chen
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|November 13, 2004
Feasibility of using tissue microarrays for the assessment of HER-2 gene amplification by fluorescence in situ hybridization in breast carcinomaRohit Bhargava, Priti Lal, Beiyun Chen
The Annals of Otology, Rhinology, and Laryngology|October 9, 2009
Delayed cerebrospinal fluid leak following septoplastyAlok Thakar, Priti Lal, Rohit Verma
American Journal of Clinical Pathology|April 22, 2005
Chromogenic in situ hybridization for the detection of HER-2/neu gene amplification in breast cancer with an emphasis on tumors with borderline and low-level amplification: does it measure up to fluorescence in situ hybridization?Rohit Bhargava, Priti Lal, Beiyun Chen
American Journal of Clinical Pathology|March 4, 2005
Correlation of HER-2 status with estrogen and progesterone receptors and histologic features in 3,655 invasive breast carcinomasPriti Lal, Lee K Tan, Beiyun Chen
American Journal of Otolaryngology|May 5, 2009
Sjogren's syndrome masquerading as nasopharyngeal carcinomaPriti Lal, S Datta Gupta, Alok Thakar
Archives of Pathology & Laboratory Medicine|December 6, 2021
Subcategorization of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens for Predicting ProgressionAnna Budina, Sahar J Farahani, Priti Lal, et al.
The Journal of Molecular Diagnostics : JMD|July 24, 2003
Impact of polysomy 17 on HER-2/neu immunohistochemistry in breast carcinomas without HER-2/neu gene amplificationPriti Lal, Paulo A Salazar, Marc Ladanyi, et al.
Pageof 12